Enfinity Global achieves Commercial Operation of First Project Under its 366 MW portfolio of PPAs with Microsoft
MILAN, Jan. 29, 2026 /PRNewswire/ -- Enfinity Global announced today the commercial…
CORRECTING and REPLACING — BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
January 27, 2026 17:10 ET | Source: BridgeBio Pharma, Inc. PALO ALTO,…
Grand Marathon Under Mumbai Climate Week Mobilizes Over 1,500 Students and Children for Climate Action
MUMBAI, India, Jan. 27, 2026 /PRNewswire/ -- In the run up to…
FDA Accepts LEQEMBI IQLIK (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimers Disease under Priority Review
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment…
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Jan.…
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:05 ET | Source: CAMP4 Therapeutics CAMBRIDGE, Mass., Jan.…
Zenas BioPharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Jan.…
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026 17:05 ET | Source: Annexon Biosciences BRISBANE, Calif., Jan.…
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:…
Tuwaiq Sculpture 2026 Returns to Riyadh for Its Seventh Edition Under the Theme “Traces of What Will Be”
RIYADH, Saudi Arabia, Jan. 14, 2026 /PRNewswire/ -- The Royal Commission for…
